
Dr. Reddy's Laboratories Limited RDY
€ 11.90
2.12%
Quartalsbericht 2022-Q1
hinzugefügt 27.06.2022
Dr. Reddy's Laboratories Limited P/S 2011-2026 | RDY
P/S Jährlich Dr. Reddy's Laboratories Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.0568 | 3.53 | -71.1 | -56 | -71.1 | -125 | -140 | 293 | - | - | 358 |
Alle Zahlen in INR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 358 | -140 | 21.3 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 21.75 | 1.59 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.91 | 1.61 % | $ 6.69 M | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.29 | 1.5 % | $ 3.69 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 102.75 | -2.57 % | $ 27.2 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.1 | 0.37 % | $ 438 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.2 | -0.26 % | $ 2.95 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.42 | -1.39 % | $ 378 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 2.99 | 2.75 % | $ 4.92 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Cardiff Oncology
CRDF
|
196 | $ 1.72 | -0.29 % | $ 115 M | ||
|
BioXcel Therapeutics
BTAI
|
24 | $ 1.07 | 0.94 % | $ 13.1 M | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 2.96 | 0.17 % | $ 297 M | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 1.95 | 1.83 % | $ 405 M | ||
|
CASI Pharmaceuticals
CASI
|
36.1 | - | - | $ 35.4 M |